Clinical Study IMP Management

In a clinical trial, the proper IMP management & compliance is of utmost importance. Our role in this process is mainly focused on the effective and diligent IMP management throughout the clinical trial conduct.

In full compliance with national and international regulations, as well as GMP, GDP and ICH-GCP guidelines, CORONIS has the required accreditations and infrastructures to undertake any of the following responsibilities pertaining to IMP management:

• receipt & storage in a secure, temperature and environmental controlled area
• labelling & packaging
• distribution to investigational sites
• transfer between investigational sites
• recall, return & destruction